Folate Receptor-Targeted Diagnostics and Therapeutics for Inflammatory Diseases

키워드

참고문헌 (50)

1. Low, P. S, "Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases", Acc. Chem. Res, 41, pp.120~129 (2008)
2. Lu, J. Y, "Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug", J. Drug Target, 7, pp.43~53 (1999)
3. Antony, A. C, "The biological chemistry of folate receptors", Blood, 79, pp.2807~2820 (1992)
4. Salazar, M. D, "The folate receptor:what does it promise in tissue-targeted therapeutics?", Cancer Metastasis Rev, 26, pp.141~152 (2007)
5. Elnakat, H, "Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy", Adv. Drug Deliv. Rev, 56, pp.1067~1084 (2004)
6. Low, P. S, "Folate receptor-targeted drugs for cancer and inflammatory diseases", Adv.Drug Deliv. Rev, 56, pp.1055~1058 (2004)
7. Kamen, B, "Folate and antifolate pharmacology", Semin. Oncol, 24, pp.S18~ (1997)
8. Goh, Y. I, "Folic acid in pregnancy and fetal outcomes", J. Obstet. Gynaecol, 28, pp.3~13 (2008)
9. Reddy, J. A, "Folate-mediated targeting of therapeutic and imaging agents to cancers", Crit. Rev. Ther. Drug Carrier Syst, 15, pp.587~627 (1998)
10. Spiegelstein, O, "Identification of two putative novel folate receptor genes in humans and mouse", Gene, 258, pp.117~125 (2000)
11. Shen, F, "Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity", Biochemistry, 34, pp.5660~5665 (1995)
12. Lacey, S. W, "Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol", J. Clin. Invest, 84, pp.715~720 (1989)
13. Shen, F, "Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity", Biochemistry, 33, pp.1209~1215 (1994)
14. Wang, X, "Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates", Biochem. Pharmacol, 44, pp.1898~1901 (1992)
15. Maziarz, K. M, "Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta", J. Biol. Chem, 274, pp.11086~11091 (1999)
16. Shen, F, "Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta", Biochemistry, 36, pp.6157~6163 (1997)
17. Weitman, S. D, "Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues", Cancer Res, 52, pp.3396~3401 (1992)
18. Weitman, S. D, "Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis", Cancer Res, 52, pp.6708~6711 (1992)
19. Toffoli, G, "Overexpression of folate binding protein in ovarian cancers", Int. J. Cancer, 74, pp.193~198 (1997)
20. Wu, M, "Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix", Cancer Epidemiol. Biomarkers Prev, 8, pp.775~782 (1999)
21. Ross, J. F, "Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia", Cancer, 85, pp.348~357 (1999)
22. Ratnam, M, "Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA", Biochemistry, 28, pp.8249~8254 (1989)
23. Reddy, J. A, "Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells", Blood, 93, pp.3940~3948 (1999)
24. Pan, X. Q, "Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid", Blood, 100, pp.594~602 (2002)
25. Nakashima-Matsushita, N, "Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis", Arthritis Rheum, 42, pp.1609~1616 (1999)
26. Turk, M. J, "Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis", Arthritis Rheum, 46, pp.1947~1955 (2002)
27. Mathias, C. J, "Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals", Nucl. Med. Biol, 30, pp.725~731 (2003)
28. Siegel, B. A, "Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results", J. Nucl. Med, 44, pp.700~707 (2003)
29. Reddy, J. A, "Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors", J. Nucl. Med, 45, pp.857~866 (2004)
30. Paulos, C. M, "Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis", Adv. Drug Deliv. Rev, 56, pp.1205~1217 (2004)
31. yala-Lopez, W, "Imaging of atherosclerosis in apoliprotein e knockout mice:targeting of a folate-conjugated radiopharmaceutical to activated macrophages", J. Nucl. Med, 51, pp.768~774 (2010)
32. Shen, J, "Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma", Mol. Pharm, 10, pp.1918~1927 (2013)
33. Mathias, C. J, "Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical", J. Nucl. Med, 39, pp.1579~1585 (1998)
34. Xia, W, "A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages", Blood, 113, pp.438~446 (2009)
35. Kraus, V. B, "Direct in vivo evidence of activated macrophages in human osteoarthritis", Osteoarthritis Cartilage, 24, pp.1613~1621 (2016)
36. Hilgenbrink, A. R, "Folate receptormediated drug targeting: from therapeutics to diagnostics", J. Pharm. Sci, 94, pp.2135~2146 (2005)
37. Lu, Y, "Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells", Int. J. Cancer, 116, pp.710~719 (2005)
38. Lu, Y, "Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential", Mol. Pharm, 4, pp.695~706 (2007)
39. Wen, Y, "Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer", Clin. Cancer Res, 21, pp.448~459 (2015)
40. Xiao Liang, "A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy", Oncotarget (2014), Impact Journals, LLC[DOI]
41. Paulos, C. M, "Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis", Arthritis Res. Ther, 8, pp.R77~ (2006)
42. Varghese, B, "Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus", Mol. Pharm, 4, pp.679~685 (2007)
43. Yi, Y. S, "Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies", Mol. Pharm, 6, pp.1228~1236 (2009)
44. Furusho, Y, "Novel therapy for atherosclerosis using recombinant immunotoxin against folate receptor betaexpressing macrophages", J. Am. Heart Assoc, 1, pp.e003079~ (2012)
45. Ferrero-Miliani, L, "Chronic inflammation: importance of NOD2and NALP3 in interleukin-1beta generation", Clin. Exp. Immunol, 147, pp.227~235 (2007)
46. 박윤정, "Proteomics in Rheumatoid Arthritis Research", Immune Network, 15(4), pp.177~185 (2015), 대한면역학회[DOI]
47. Sheng Yan, "MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis", Immune Network, 14(3), pp.138~148 (2014), 대한면역학회
48. 배세연, "Identification of CM1 as a Pathogenic Factor in Inflammatory Diseases and Cancer", Immune Network, 11(3), pp.175~181 (2011), 대한면역학회
49. 우연덕, "The Roles of Innate Lymphoid Cells in the Development of Asthma", Immune Network, 14(4), pp.171~181 (2014), 대한면역학회
50. Paola Italiani, "New Insights Into Tissue Macrophages: From Their Origin to the Development of Memory", Immune Network, 15(4), pp.167~176 (2015), 대한면역학회[DOI]

관련 논문AI추천